CGEM (NASDAQ: CGEM) Form 144 shows 1,752-share proposed resale; insider sales listed
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
CGEM filing shows a proposed resale of 1,752 shares of common stock through Morgan Stanley Smith Barney LLC.
The filing lists multiple recent 10b5-1 sales by Jennifer Michaelson, including 8,000 shares sold on 02/20/2026 for $114,400.00 and 4,000 shares sold on 01/22/2026 for $49,200.00.
Positive
- None.
Negative
- None.
FAQ
What does the CGEM Form 144 disclose?
The filing discloses a proposed resale of 1,752 shares of common stock through Morgan Stanley Smith Barney LLC. It also lists recent 10b5-1 sales by Jennifer Michaelson on specific dates with share counts and proceeds.
Who executed the recent sales reported in the filing for CGEM?
The filing lists multiple 10b5-1 sales executed by Jennifer Michaelson. Examples include 8,000 shares on 02/20/2026 and 4,000 shares on 01/22/2026, with stated proceeds.
How much proceeded from the 02/20/2026 sale in the CGEM filing?
The sale on 02/20/2026 of 8,000 shares shows proceeds of $114,400.00. The filing lists individual sale dates, share counts, and proceeds for several transactions.
Are these sales part of a trading plan for CGEM insiders?
Yes. The transactions are listed as 10b5-1 sales, indicating they were executed under an established trading plan. The filing enumerates dates, share counts, and proceeds for each reported sale.
Does the Form 144 list who is handling the resale for CGEM?
The resale is being processed through Morgan Stanley Smith Barney LLC, Executive Financial Services. The filing identifies the broker and provides the number of shares listed for resale (1,752 shares).